← Back to Search

Serious Games for Parkinson's Disease

N/A
Recruiting
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of mild to moderate PD (Hoehn & Yahr 1-3)
Baseline MoCA score <26
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (week 0), post-intervention (week 12), follow-up (week 24)
Awards & highlights

Study Summary

This trial will explore whether self-administered rehabilitation games can help improve cognitive function, depression, quality of life, and mobility for patients with Parkinson's disease.

Who is the study for?
This trial is for English-speaking adults (18+) with mild to moderate Parkinson's Disease, as indicated by a Hoehn & Yahr stage of 1-3. Participants should have some comfort with technology and access to WiFi at home. Those with severe vision impairments or cognitive issues that would hinder task performance, or who do not wish to be recorded during sessions are excluded.Check my eligibility
What is being tested?
The study tests if 'serious games'—video games designed for rehabilitation—can improve cognitive function when used at home by people with Parkinson's Disease. It involves playing these games for two 30-minute sessions weekly over three months, alongside usual care, compared to a control group receiving only usual care.See study design
What are the potential side effects?
Since the intervention involves non-invasive video games designed for therapeutic purposes, no direct medical side effects are expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have been diagnosed with mild to moderate Parkinson's disease (Hoehn & Yahr stages 1-3).
Select...
Your MoCA score is less than 26 before starting the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (week 0), post-intervention (week 12), follow-up (week 24)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (week 0), post-intervention (week 12), follow-up (week 24) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Montreal Cognitive Assessment (MoCA)
Secondary outcome measures
Digit span forward and backward
Mental Depression
LifeSpace Assessment
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Patients will be asked to perform two 30-minute sessions per week of training using serious games over a 3-month period in their home setting in addition to their conventional care
Group II: ControlActive Control1 Intervention
Patients will undergo only their conventional care

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
424 Previous Clinical Trials
64,113 Total Patients Enrolled

Media Library

Serious games Clinical Trial Eligibility Overview. Trial Name: NCT05551338 — N/A
Parkinson's Disease Research Study Groups: Intervention, Control
Parkinson's Disease Clinical Trial 2023: Serious games Highlights & Side Effects. Trial Name: NCT05551338 — N/A
Serious games 2023 Treatment Timeline for Medical Study. Trial Name: NCT05551338 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the sample size of participants involved in this research project?

"Affirmative. According to the clinicaltrials.gov database, this study is actively enrolling volunteers; it was first listed on June 15th 2022 and most recently updated on September 19th of the same year. A total of 20 participants will be accepted at a single location."

Answered by AI

Are there openings for individuals to join this clinical investigation?

"This medical research is actively searching for subjects. The clinical trial was initially advertised on June 15th 2022, and the most recent update can be found from September 19th 2022."

Answered by AI

Who else is applying?

What state do they live in?
New Jersey
What site did they apply to?
Rutgers University
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
3+
~7 spots leftby Mar 2025